Tag: drug

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

Reinforces Seer’s Clear Strategy, Strong Governance and Significant Long-Term Value Creation Opportunity

MONCTON, New Brunswick, June 03, 2026 (GLOBE NEWSWIRE) -- The families and friends of innocent victims killed in alcohol and drug-related crashes will gather for a special ceremony of Hope and Dedication at MADD Canada’s New Brunswick Memorial Monument.

QUEBEC CITY, June 03, 2026 (GLOBE NEWSWIRE) -- Media is invited to attend MADD Canada’s Quebec Provincial Memorial ceremony in honour of those who have been killed in alcohol and/or drug-related crashes. This year, three more names have been added to the Memorial: Marie-Jade Kuncer, Jolyane Potvin, and Derek Godin-Rioux, raising the total number of victims to 61.